
Effects of combination of RTA dh404 and dapagliflozin on renal involvement and body composition in experimental rat model of diabetic kidney disease
Key Word:
RTA dh404(合成オレアナントリテルペノイド化合物)、Dapagliflozin(ダパグリフロジン)、Renal involvement(腎障害)、Diabetic kidney disease(糖尿病性腎臓症:DKD)、obese, type 2 diabetic model(肥満、2型糖尿病モデル)、SDT fatty/Jcl(SDT fatty ラット)
Kei Fukami1, Kanji Ota1, Goh Kodama1, Yunosuke Yokota1, Masami Shinohara2, Sakuya Ito1
1Division of Nephrology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan
2Tokyo Animal & Diet Dept. CLEA Japan, Inc, Tokyo, Japan
For more details, please click here (Google Search)
- ISN/WCN2022: Kuala Lumpur, Malaysia (on online streaming)
- February 24-27, 2022
Related CLEA Japan product: SDT fatty/Jcl
For the animal model, please click here ▼
https://www.clea-japan.com/en/products/diabetes/item_a0150
https://www.clea-japan.com/products/diabetes/item_a0150
Inquiry(お問い合わせ)
If you have any questions, please feel free to contact us.